Elevation Oncology Ownership | Who Owns Elevation Oncology?

Elevation Oncology Ownership Summary

Elevation Oncology is owned by 49.92% institutional investors, 0.36% insiders, and 49.72% retail investors. Frazier life sciences management is the largest institutional shareholder, holding 10.13% of ELEV shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.76% of its assets in Elevation Oncology shares.

ELEV Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Elevation Oncology	49.92%	0.36%	49.72%
Sector	Healthcare Stocks	479.67%	11.03%	-390.70%
Industry	Biotech Stocks	295.80%	10.97%	-206.77%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Frazier life sciences management	5.99M	10.13%	$2.20M
Bml capital management	5.89M	9.95%	$2.16M
Aisling capital management lp	2.83M	4.79%	$1.04M
Vanguard group	2.61M	4.42%	$1.47M
Blackrock	2.49M	4.22%	$6.72M
Goldman sachs group	1.65M	2.79%	$929.26K
Renaissance	1.60M	2.71%	$902.02K
Deltec asset management	1.44M	2.43%	$527.29K
Morgan stanley	1.27M	2.16%	$3.44M
Geode capital management	1.16M	1.96%	$651.36K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Bml capital management	5.89M	1.64%	$2.16M
Aisling capital management lp	2.83M	0.29%	$1.04M
Deltec asset management	1.44M	0.09%	$527.29K
Frazier life sciences management	5.99M	0.09%	$2.20M
Artal group	1.01M	0.07%	$2.74M
Palumbo wealth management	295.33K	0.03%	$108.42K
Yakira capital management	263.10K	0.03%	$96.58K
Sphera funds management	328.56K	0.03%	$120.61K
Exome asset management	110.35K	0.03%	$40.51K
Penderfund capital management	195.70K	0.02%	$71.84K

Top Buyers

Holder	Shares	% Assets	Change
Blackrock	2.49M	0.00%	2.32M
Deltec asset management	1.44M	0.09%	1.44M
Morgan stanley	1.27M	0.00%	1.25M
Exoduspoint capital management, lp	597.02K	0.00%	597.02K
Gts securities	300.03K	0.00%	300.03K

Top Sellers

Holder	Shares	% Assets	Change
Tang capital management	-	-	-4.76M
Logos global management lp	-	-	-3.85M
Farallon capital management	-	-	-3.53M
Bvf inc/il	-	-	-2.97M
Blackrock funding, inc. /de	369.05K	-	-2.81M

New Positions

Holder	Shares	% Assets	Change	Value
Deltec asset management	1.44M	0.09%	1.44M	$527.29K
Exoduspoint capital management, lp	597.02K	0.00%	597.02K	$219.00K
Gts securities	300.03K	0.00%	300.03K	$110.11K
Yakira capital management	263.10K	0.03%	263.10K	$96.58K
Penderfund capital management	195.70K	0.02%	195.70K	$71.84K

Sold Out

Holder	Change
Capital performance advisors llp	-11.00
Sterling capital management	-416.00
Nisa investment advisors	-1.16K
Macquarie group	-1.27K
Amalgamated bank	-1.80K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2025	65	-9.72%	29,541,166	-12.72%	49	1.53%	36	9.09%	24	9.09%
Mar 31, 2025	4	-94.44%	6,773,820	-83.05%	11	0.25%	-	-100.00%	1	-92.31%
Dec 31, 2024	71	2.90%	33,979,478	-26.03%	57	0.95%	39	-	13	-23.53%
Sep 30, 2024	69	-14.81%	45,936,801	-11.86%	77	1.00%	39	-25.00%	17	-19.05%
Jun 30, 2024	81	26.56%	52,117,516	18.46%	88	1.02%	52	1.96%	21	133.33%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	1.64M	2.76%	-
Aesculape SRI IC	755.00K	1.27%	-
Vanguard Institutional Extnd Mkt Idx Tr	608.57K	1.03%	-
Fidelity Small Cap Index	580.25K	0.98%	-
Vanguard US Momentum Factor ETF	430.42K	0.73%	430.42K
State St Russell Sm/Mid Cp® Indx NL Cl C	300.71K	0.51%	-
State St Russell Sm/Mid Cp® Indx SL Cl I	300.71K	0.51%	-
Fidelity Extended Market Index	282.78K	0.48%	-738.00
Vanguard Russell 2000 ETF	262.16K	0.44%	2.54K
State St Russell Sm Cap® Indx SL Cl I	241.40K	0.41%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
May 25, 2022	venBio Global Strategic Fund III, L.P.	-	Sell	$2.90M
May 25, 2022	Royston Aaron		Sell	$2.90M
Jun 29, 2021	Qiming U.S. Healthcare Fund II, L.P.	-	Buy	$5.00M
Jun 29, 2021	Aisling Capital IV, LP	-	Buy	$3.00M
Jun 29, 2021	venBio Global Strategic Fund III, L.P.	-	Buy	$10.00M

Insider Transactions Trends

Date	Buy	Sell
2025 Q3	-	-
2025 Q2	-	-
2025 Q1	-	-
2024 Q4	-	-
2024 Q3	-	-

ELEV Ownership FAQ

Who Owns Elevation Oncology?

Elevation Oncology shareholders are primarily institutional investors at 49.92%, followed by 0.36% insiders and 49.72% retail investors. The average institutional ownership in Elevation Oncology's industry, Biotech Stocks , is 295.80%, which Elevation Oncology falls below.

Who owns the most shares of Elevation Oncology?

Elevation Oncology’s largest shareholders are Frazier life sciences management (5.99M shares, 10.13%), Bml capital management (5.89M shares, 9.95%), and Aisling capital management lp (2.83M shares, 4.79%). Together, they hold 24.87% of Elevation Oncology’s total shares outstanding.

Does Blackrock own Elevation Oncology?

Yes, BlackRock owns 4.22% of Elevation Oncology, totaling 2.49M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 6.72M$. In the last quarter, BlackRock increased its holdings by 2.32M shares, a 1348.65% change.

Who is Elevation Oncology’s biggest shareholder by percentage of total assets invested?

Bml capital management is Elevation Oncology’s biggest shareholder by percentage of total assets invested, with 1.64% of its assets in 5.89M Elevation Oncology shares, valued at 2.16M$.

Who is the top mutual fund holder of Elevation Oncology shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Elevation Oncology shares, with 2.76% of its total shares outstanding invested in 1.64M Elevation Oncology shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools